HK Stock MarketDetailed Quotes

01858 CHUNLI MEDICAL

Watchlist
  • 8.580
  • +0.170+2.02%
Market Closed Nov 12 16:08 CST
3.29BMarket Cap18.73P/E (TTM)

CHUNLI MEDICAL Key Stats

All
YOY yoy
Hide blank lines yoy
(Q9)Sep 30, 2024
(Q6)Jun 30, 2024
(Q3)Mar 31, 2024
(FY)Dec 31, 2023
(Q9)Sep 30, 2023
(Q6)Jun 30, 2023
(Q3)Mar 31, 2023
(FY)Dec 31, 2022
(Q9)Sep 30, 2022
(Q6)Jun 30, 2022
Cash flow from operating activities
Earning before tax
----
-37.33%78.96M
----
-9.72%277.82M
----
-19.75%125.99M
----
-4.54%307.72M
----
0.92%156.98M
Profit adjustment
Investment loss (gain)
----
39.56%-6.08M
----
-78.01%-12.01M
----
-183.00%-10.07M
----
---6.75M
----
---3.56M
Impairment and provisions:
----
-7.86%11.02M
----
-17.33%25.02M
----
-28.70%11.96M
----
10.91%30.27M
----
63.90%16.78M
-Other impairments and provisions
----
-34.07%5.79M
----
-74.34%4.32M
----
-38.59%8.79M
----
0.25%16.82M
----
49.07%14.31M
Revaluation surplus:
----
-6.57%-4.67M
----
-1.27%-9.61M
----
-10.60%-4.38M
----
---9.49M
----
---3.96M
Asset sale loss (gain):
----
---39.21K
----
84.57%-3.9K
----
----
----
-70.33%-25.31K
----
-208.84%-25.31K
-Loss (gain) on sale of property, machinery and equipment
----
---39.21K
----
84.57%-3.9K
----
----
----
-70.33%-25.31K
----
-208.84%-25.31K
Depreciation and amortization:
----
15.30%18.65M
----
14.90%34.66M
----
21.74%16.18M
----
62.81%30.16M
----
52.26%13.29M
-Amortization of intangible assets
----
15.89%5.36M
----
38.14%10.78M
----
57.63%4.63M
----
114.53%7.81M
----
97.28%2.94M
-Other depreciation and amortization
----
----
----
----
----
----
----
-41.67%128.33K
----
0.00%110K
Financial expense
----
-97.99%-1.26M
----
100.60%90.11K
----
-93.84%-634.25K
----
-107.87%-15.01M
----
91.55%-327.2K
Change of operating capital
Inventory (increase) decrease
----
29.17%-91.14M
----
-70.22%-193.31M
----
-412.51%-128.68M
----
-7,093.76%-113.56M
----
-112.66%-25.11M
Accounts receivable (increase)decrease
----
-51.70%11.8M
----
171.54%294.85M
----
111.08%24.43M
----
-83.12%-412.17M
----
-159.03%-220.52M
Accounts payable increase (decrease)
----
-17.12%-89.39M
----
-58.85%94.75M
----
-337.45%-76.32M
----
642.73%230.27M
----
69.13%-17.45M
Special items of business
----
20.60%3.09M
----
-33.83%-539.07K
----
7.55%2.56M
----
19.74%-402.79K
----
35.42%2.38M
Adjustment items of business operations
-225.68%-17.28M
-73.71%-72.14M
-7.83%-129.61M
1,137.02%512.25M
118.00%13.75M
50.49%-41.53M
-497.38%-120.2M
-74.95%41.41M
-231.72%-76.37M
-587.98%-83.89M
Net cash from operations
-225.68%-17.28M
-77.20%-69.06M
-7.83%-129.61M
1,147.85%511.71M
118.00%13.75M
52.19%-38.97M
-497.38%-120.2M
-75.11%41.01M
-231.72%-76.37M
-530.17%-81.51M
Cash flow from investment activities
Dividend received - investment
-5.80%12.96M
-16.35%11.46M
-11.16%5.49M
65.56%22.37M
11.79%13.75M
105.10%13.7M
--6.18M
--13.51M
--12.3M
--6.68M
Sale of fixed assets
--89.09K
--21K
--437.73K
-90.39%6.1K
----
----
----
43.78%63.5K
86.76%63.5K
86.76%63.5K
Purchase of fixed assets
6.88%-32.22M
-14.11%-21.84M
-1,215.97%-13.5M
-33.48%-33.24M
39.64%-34.6M
29.37%-19.14M
95.17%-1.03M
87.51%-24.9M
68.74%-57.32M
76.00%-27.1M
Acquisition of subsidiaries
----
----
----
---6.99M
---6.99M
---3.69M
---9.6M
----
----
----
Recovery of cash from investments
2.93%1.57B
-7.49%1.41B
8.67%831.3M
66.57%2.35B
-0.83%1.53B
65.67%1.52B
--765M
--1.41B
--1.54B
--920M
Cash on investment
5.00%-1.5B
16.40%-1.32B
2.50%-740M
-10.86%-2.41B
22.14%-1.58B
-11.99%-1.58B
-13.28%-759M
---2.17B
---2.03B
---1.41B
Other items in the investment business
----
----
----
----
----
----
----
52.11%13.72M
----
----
Net cash from investment operations
162.34%50.83M
224.56%79.64M
5,297.49%83.73M
89.31%-81.56M
84.76%-81.53M
87.47%-63.93M
100.22%1.55M
-300.64%-762.61M
-203.02%-534.95M
-370.44%-510.36M
Net cash before financing
149.49%33.55M
110.28%10.58M
61.33%-45.89M
159.61%430.16M
88.91%-67.79M
82.61%-102.91M
83.30%-118.65M
-2,723.04%-721.6M
-415.61%-611.32M
-561.04%-591.87M
Cash flow from financing activities
Dividends paid - financing
-15.59%-138.77M
----
----
-140.32%-120.06M
-139.92%-120.06M
----
----
---49.96M
---50.04M
---36.94M
Other items of the financing business
-673.26%-5.59M
-318.43%-554.4K
----
85.93%-1.28M
91.78%-722.7K
88.93%-132.5K
---202.69K
-313.55%-9.08M
-421.72%-8.79M
6.34%-1.2M
Net cash from financing operations
-19.52%-144.36M
-318.43%-554.4K
----
-105.53%-121.33M
-105.30%-120.78M
99.65%-132.5K
---202.69K
-105.50%-59.04M
-3,391.42%-58.83M
-2,884.11%-38.13M
Effect of rate
-99.75%1.68K
90.45%1.28M
---4.21K
-100.31%-4.21K
-67.29%673.56K
86.11%673.56K
----
177.70%1.34M
411.30%2.06M
176.98%361.91K
Net Cash
41.24%-110.81M
109.73%10.02M
61.39%-45.89M
139.56%308.82M
71.86%-188.56M
83.64%-103.04M
83.27%-118.85M
-174.48%-780.64M
-457.31%-670.15M
-593.73%-630M
Begining period cash
32.26%1.27B
32.26%1.27B
32.26%1.27B
-44.88%957.19M
-44.88%957.19M
-44.88%957.19M
-44.88%957.19M
151.62%1.74B
151.62%1.74B
151.62%1.74B
Cash at the end
50.16%1.16B
49.42%1.28B
45.54%1.22B
32.26%1.27B
-28.00%769.3M
-22.77%854.83M
-18.28%838.34M
-44.88%957.19M
87.70%1.07B
84.83%1.11B
Cash balance analysis
Currency Unit
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
Accounting Standards
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
Audit Opinions
--
--
--
Unqualified Opinion
--
--
--
Unqualified Opinion
--
--
Auditor
--
--
--
Daxin Certified Public Accountants (Special General Partnership)
--
--
--
Daxin Certified Public Accountants (Special General Partnership)
--
--
(Q9)Sep 30, 2024 (Q6)Jun 30, 2024 (Q3)Mar 31, 2024 (FY)Dec 31, 2023 (Q9)Sep 30, 2023 (Q6)Jun 30, 2023 (Q3)Mar 31, 2023 (FY)Dec 31, 2022 (Q9)Sep 30, 2022 (Q6)Jun 30, 2022
Cash flow from operating activities
Earning before tax ---- -37.33%78.96M ---- -9.72%277.82M ---- -19.75%125.99M ---- -4.54%307.72M ---- 0.92%156.98M
Profit adjustment
Investment loss (gain) ---- 39.56%-6.08M ---- -78.01%-12.01M ---- -183.00%-10.07M ---- ---6.75M ---- ---3.56M
Impairment and provisions: ---- -7.86%11.02M ---- -17.33%25.02M ---- -28.70%11.96M ---- 10.91%30.27M ---- 63.90%16.78M
-Other impairments and provisions ---- -34.07%5.79M ---- -74.34%4.32M ---- -38.59%8.79M ---- 0.25%16.82M ---- 49.07%14.31M
Revaluation surplus: ---- -6.57%-4.67M ---- -1.27%-9.61M ---- -10.60%-4.38M ---- ---9.49M ---- ---3.96M
Asset sale loss (gain): ---- ---39.21K ---- 84.57%-3.9K ---- ---- ---- -70.33%-25.31K ---- -208.84%-25.31K
-Loss (gain) on sale of property, machinery and equipment ---- ---39.21K ---- 84.57%-3.9K ---- ---- ---- -70.33%-25.31K ---- -208.84%-25.31K
Depreciation and amortization: ---- 15.30%18.65M ---- 14.90%34.66M ---- 21.74%16.18M ---- 62.81%30.16M ---- 52.26%13.29M
-Amortization of intangible assets ---- 15.89%5.36M ---- 38.14%10.78M ---- 57.63%4.63M ---- 114.53%7.81M ---- 97.28%2.94M
-Other depreciation and amortization ---- ---- ---- ---- ---- ---- ---- -41.67%128.33K ---- 0.00%110K
Financial expense ---- -97.99%-1.26M ---- 100.60%90.11K ---- -93.84%-634.25K ---- -107.87%-15.01M ---- 91.55%-327.2K
Change of operating capital
Inventory (increase) decrease ---- 29.17%-91.14M ---- -70.22%-193.31M ---- -412.51%-128.68M ---- -7,093.76%-113.56M ---- -112.66%-25.11M
Accounts receivable (increase)decrease ---- -51.70%11.8M ---- 171.54%294.85M ---- 111.08%24.43M ---- -83.12%-412.17M ---- -159.03%-220.52M
Accounts payable increase (decrease) ---- -17.12%-89.39M ---- -58.85%94.75M ---- -337.45%-76.32M ---- 642.73%230.27M ---- 69.13%-17.45M
Special items of business ---- 20.60%3.09M ---- -33.83%-539.07K ---- 7.55%2.56M ---- 19.74%-402.79K ---- 35.42%2.38M
Adjustment items of business operations -225.68%-17.28M -73.71%-72.14M -7.83%-129.61M 1,137.02%512.25M 118.00%13.75M 50.49%-41.53M -497.38%-120.2M -74.95%41.41M -231.72%-76.37M -587.98%-83.89M
Net cash from operations -225.68%-17.28M -77.20%-69.06M -7.83%-129.61M 1,147.85%511.71M 118.00%13.75M 52.19%-38.97M -497.38%-120.2M -75.11%41.01M -231.72%-76.37M -530.17%-81.51M
Cash flow from investment activities
Dividend received - investment -5.80%12.96M -16.35%11.46M -11.16%5.49M 65.56%22.37M 11.79%13.75M 105.10%13.7M --6.18M --13.51M --12.3M --6.68M
Sale of fixed assets --89.09K --21K --437.73K -90.39%6.1K ---- ---- ---- 43.78%63.5K 86.76%63.5K 86.76%63.5K
Purchase of fixed assets 6.88%-32.22M -14.11%-21.84M -1,215.97%-13.5M -33.48%-33.24M 39.64%-34.6M 29.37%-19.14M 95.17%-1.03M 87.51%-24.9M 68.74%-57.32M 76.00%-27.1M
Acquisition of subsidiaries ---- ---- ---- ---6.99M ---6.99M ---3.69M ---9.6M ---- ---- ----
Recovery of cash from investments 2.93%1.57B -7.49%1.41B 8.67%831.3M 66.57%2.35B -0.83%1.53B 65.67%1.52B --765M --1.41B --1.54B --920M
Cash on investment 5.00%-1.5B 16.40%-1.32B 2.50%-740M -10.86%-2.41B 22.14%-1.58B -11.99%-1.58B -13.28%-759M ---2.17B ---2.03B ---1.41B
Other items in the investment business ---- ---- ---- ---- ---- ---- ---- 52.11%13.72M ---- ----
Net cash from investment operations 162.34%50.83M 224.56%79.64M 5,297.49%83.73M 89.31%-81.56M 84.76%-81.53M 87.47%-63.93M 100.22%1.55M -300.64%-762.61M -203.02%-534.95M -370.44%-510.36M
Net cash before financing 149.49%33.55M 110.28%10.58M 61.33%-45.89M 159.61%430.16M 88.91%-67.79M 82.61%-102.91M 83.30%-118.65M -2,723.04%-721.6M -415.61%-611.32M -561.04%-591.87M
Cash flow from financing activities
Dividends paid - financing -15.59%-138.77M ---- ---- -140.32%-120.06M -139.92%-120.06M ---- ---- ---49.96M ---50.04M ---36.94M
Other items of the financing business -673.26%-5.59M -318.43%-554.4K ---- 85.93%-1.28M 91.78%-722.7K 88.93%-132.5K ---202.69K -313.55%-9.08M -421.72%-8.79M 6.34%-1.2M
Net cash from financing operations -19.52%-144.36M -318.43%-554.4K ---- -105.53%-121.33M -105.30%-120.78M 99.65%-132.5K ---202.69K -105.50%-59.04M -3,391.42%-58.83M -2,884.11%-38.13M
Effect of rate -99.75%1.68K 90.45%1.28M ---4.21K -100.31%-4.21K -67.29%673.56K 86.11%673.56K ---- 177.70%1.34M 411.30%2.06M 176.98%361.91K
Net Cash 41.24%-110.81M 109.73%10.02M 61.39%-45.89M 139.56%308.82M 71.86%-188.56M 83.64%-103.04M 83.27%-118.85M -174.48%-780.64M -457.31%-670.15M -593.73%-630M
Begining period cash 32.26%1.27B 32.26%1.27B 32.26%1.27B -44.88%957.19M -44.88%957.19M -44.88%957.19M -44.88%957.19M 151.62%1.74B 151.62%1.74B 151.62%1.74B
Cash at the end 50.16%1.16B 49.42%1.28B 45.54%1.22B 32.26%1.27B -28.00%769.3M -22.77%854.83M -18.28%838.34M -44.88%957.19M 87.70%1.07B 84.83%1.11B
Cash balance analysis
Currency Unit CNY CNY CNY CNY CNY CNY CNY CNY CNY CNY
Accounting Standards CAS (2007) CAS (2007) CAS (2007) CAS (2007) CAS (2007) CAS (2007) CAS (2007) CAS (2007) CAS (2007) CAS (2007)
Audit Opinions -- -- -- Unqualified Opinion -- -- -- Unqualified Opinion -- --
Auditor -- -- -- Daxin Certified Public Accountants (Special General Partnership) -- -- -- Daxin Certified Public Accountants (Special General Partnership) -- --

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
HK
Overall
Symbol
Latest Price
% Chg

No Data